BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Elshazli RM, Toraih EA, Elgaml A, El-Mowafy M, El-Mesery M, Amin MN, Hussein MH, Killackey MT, Fawzy MS, Kandil E. Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients. PLoS One. 2020;15:e0238160. [PMID: 32822430 DOI: 10.1371/journal.pone.0238160] [Cited by in Crossref: 97] [Cited by in F6Publishing: 106] [Article Influence: 32.3] [Reference Citation Analysis]
Number Citing Articles
1 Chapola H, de Bastiani MA, Duarte MM, Freitas MB, Schuster JS, de Vargas DM, Klamt F. A COMPARATIVE STUDY OF COVID-19 TRANSCRIPTIONAL SIGNATURES BETWEEN CLINICAL SAMPLES AND PRECLINICAL CELL MODELS IN THE SEARCH FOR DISEASE MASTER REGULATORS AND DRUG REPOSITIONING CANDIDATES. Virus Res 2023;:199053. [PMID: 36709793 DOI: 10.1016/j.virusres.2023.199053] [Reference Citation Analysis]
2 Sebbar EH, Choukri M. Interleukin 6: A biomarker for COVID-19 progression. Mater Today Proc 2023;72:3351-5. [PMID: 35937954 DOI: 10.1016/j.matpr.2022.07.387] [Reference Citation Analysis]
3 Bhardwaj T, Somvanshi P. Applications of multiomics data in COVID-19. Omics Approaches and Technologies in COVID-19 2023. [DOI: 10.1016/b978-0-323-91794-0.00004-4] [Reference Citation Analysis]
4 Amodio G, Capogrosso P, Pontillo M, Tassara M, Boeri L, Carenzi C, Cignoli D, Ferrara AM, Ramirez GA, Tresoldi C, Locatelli M, Santoleri L, Castagna A, Zangrillo A, De Cobelli F, Tresoldi M, Landoni G, Rovere-Querini P, Ciceri F, Montorsi F, Salonia A, Gregori S. Combined plasma levels of IL-10 and testosterone, but not soluble HLA-G5, predict the risk of death in COVID-19 patients. Andrology 2023;11:32-44. [PMID: 36323494 DOI: 10.1111/andr.13334] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ferreira DD, Santos LO, Alvarenga TA, Rodríguez DZ, Barbosa BHG, Ferreira ACBH, dos Santos Alves DF, Carmona EV, Duran ECM, de Moraes Lopes MHB. Applications of digital and smart technologies to control SARS-CoV-2 transmission, rapid diagnosis, and monitoring. Omics Approaches and Technologies in COVID-19 2023. [DOI: 10.1016/b978-0-323-91794-0.00018-4] [Reference Citation Analysis]
6 Semiz S. COVID19 biomarkers: What did we learn from systematic reviews? Front Cell Infect Microbiol 2022;12:1038908. [PMID: 36583110 DOI: 10.3389/fcimb.2022.1038908] [Reference Citation Analysis]
7 Bizjak DA, John L, Matits L, Uhl A, Schulz SVW, Schellenberg J, Peifer J, Bloch W, Weiß M, Grüner B, Bracht H, Steinacker JM, Grau M. SARS-CoV-2 Altered Hemorheological and Hematological Parameters during One-Month Observation Period in Critically Ill COVID-19 Patients. Int J Mol Sci 2022;23. [PMID: 36499657 DOI: 10.3390/ijms232315332] [Reference Citation Analysis]
8 Horvath A, Lind T, Frece N, Wurzer H, Stadlbauer V. Validation of a simple risk stratification tool for COVID-19 mortality. Front Med (Lausanne) 2022;9:1016180. [PMID: 36304183 DOI: 10.3389/fmed.2022.1016180] [Reference Citation Analysis]
9 Zini G, d'Onofrio G. Coronavirus disease 2019 (COVID-19): Focus on peripheral blood cell morphology. Br J Haematol 2023;200:404-19. [PMID: 36203344 DOI: 10.1111/bjh.18489] [Reference Citation Analysis]
10 Wifi MN, Morad MA, El Sheemy R, Abdeen N, Afify S, Abdalgaber M, Abdellatef A, Zaghloul M, Alboraie M, El-Kassas M. Hemostatic system and COVID-19 crosstalk: A review of the available evidence. World J Methodol 2022; 12(5): 331-349 [DOI: 10.5662/wjm.v12.i5.331] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Anasiz M, Kuzay D. Investigation of the Disease Process and Some Blood Parameters of Patients with COVID-19 Positive Diagnosis Registered at The Family Health Center. Van Sağ Bil Derg 2022. [DOI: 10.52976/vansaglik.1022178] [Reference Citation Analysis]
12 Griffith LE, Ali MU, Andreacchi A, Loeb M, Kenny M, Joshi D, Mokashi V, Irshad A, Ulrich AK, Basta NE, Raina P, Anderson L, Balion C. The complexity of examining laboratory-based biological markers associated with mortality in hospitalized patients during early phase of the COVID-19 pandemic: A systematic review and evidence map. PLoS ONE 2022;17:e0273578. [DOI: 10.1371/journal.pone.0273578] [Reference Citation Analysis]
13 Pál K, Molnar AA, Huțanu A, Szederjesi J, Branea I, Timár Á, Dobreanu M. Inflammatory Biomarkers Associated with In-Hospital Mortality in Critical COVID-19 Patients. IJMS 2022;23:10423. [DOI: 10.3390/ijms231810423] [Reference Citation Analysis]
14 Nesari T, Kadam S, Vyas M, Huddar VG, Prajapati PK, Rajagopala M, More A, Rajagopala SK, Bhatted SK, Yadav RK, Mahanta V, Mandal SK, Mahto RR, Kajaria D, Sherkhane R, Bavalatti N, Kundal P, Dharmarajan P, Bhojani M, Bhide B, Harti SK, Mahapatra AK, Tagade U, Ruknuddin G, Venkatramana Sharma AP, Rai S, Ghildiyal S, Yadav PR, Sandrepogu J, Deogade M, Pathak P, Kapoor A, Kumar A, Saini H, Tripathi R. AYURAKSHA, a prophylactic Ayurvedic immunity boosting kit reducing positivity percentage of IgG COVID-19 among frontline Indian Delhi police personnel: A non-randomized controlled intervention trial. Front Public Health 2022;10:920126. [PMID: 36052011 DOI: 10.3389/fpubh.2022.920126] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Tekle E, Gelaw Y, Dagnew M, Gelaw A, Negash M, Kassa E, Bizuneh S, Wudineh D, Asrie F. Risk stratification and prognostic value of prothrombin time and activated partial thromboplastin time among COVID-19 patients. PLoS ONE 2022;17:e0272216. [DOI: 10.1371/journal.pone.0272216] [Reference Citation Analysis]
16 Zangeneh M, Tarjoman T, Shahidi A, Valizadeh M, Hanifezadeh Z, Ameli O, Saljoughi N, Farhoodi B, Mesgarian M, Department of Infection Disease, Faculty of Medicine, Amir-al-Momenin Hospital Tehran Medical Sciences, Islamic Azad University Tehran, Iran, Social Determinants of Health Research Center, Amir-al-Momenin Hospital Tehran Medical Sciences, Islamic Azad University Tehran, Iran, MD, Faculty of Medicine, Amir-al-Momenin Hospital Tehran Medical Sciences, Islamic Azad University Tehran, Iran, Department of Internal Disease, Faculty of Medicine, Amir-al-Momenin Hospital Tehran Medical Sciences, Islamic Azad University Tehran, Iran, Bachelor of Midwifery, Amir-al-Momenin Hospital Tehran Medical Sciences, Islamic Azad University Tehran, Iran, Nursing Student, Amir-al-Momenin Hospital Tehran Medical Sciences, Branch, Islamic Azad University Tehran, Iran, MD, Faculty of Medicine, Amir-al-Momenin Hospital Tehran Medical Sciences, Islamic Azad University Tehran, Iran, Department of Infection Disease, Faculty of Medicine, Amir-al-Momenin Hospital Tehran Medical Sciences, Islamic Azad University Tehran, Iran, Department of Infection Disease, Faculty of Medicine, Amir-al-Momenin Hospital Tehran Medical Sciences, Islamic Azad University Tehran, Iran. The relationship between laboratory and chest computed tomography scan findings and severity of COVID-19 cases: a single center study. MEDICAL SCIENCES 2022;32:185-195. [DOI: 10.52547/iau.32.2.185] [Reference Citation Analysis]
17 Fajrunni'mah R, Rada F, Widhyasih RM. Relationship between Procalcitonin Levels (PCT) and Disease Severity in Hospitalized Patients Confirmed Positive for COVID-19. j info kesehat 2022;20:41-48. [DOI: 10.31965/infokes.vol20.iss1.638] [Reference Citation Analysis]
18 Schneider M. The Role of Biomarkers in Hospitalized COVID-19 Patients With Systemic Manifestations. Biomark�Insights 2022;17:117727192211089. [DOI: 10.1177/11772719221108909] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Abo-haded HM, Alshengeti AM, Alawfi AD, Khoshhal SQ, Al-harbi KM, Allugmani MD, El-agamy DS. Cytokine Profiling among Children with Multisystem Inflammatory Syndrome versus Simple COVID-19 Infection: A Study from Northwest Saudi Arabia. Biology 2022;11:946. [DOI: 10.3390/biology11070946] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Asrie F, Tekle E, Gelaw Y, Dagnew M, Gelaw A, Negash M, Kassa E, Bizuneh S, Wudineh D. Baseline Thrombocytopenia and Disease Severity Among COVID-19 Patients, Tibebe Ghion Specialized Hospital COVID-19 Treatment Center, Northwest Ethiopia. J Blood Med 2022;13:315-25. [PMID: 35712680 DOI: 10.2147/JBM.S366478] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Asaduzzaman M, Nazmul Alam ZHM, Zabed Jillul Bari M, Jahangir Alam MM, Ranjan Chakraborty S, Ferdousi T. Clinical Characteristics and Predictors of Mortality in Elderly Patients Hospitalized with COVID-19 in Bangladesh: A Multicenter, Retrospective Study. Interdiscip Perspect Infect Dis 2022;2022:5904332. [PMID: 35698592 DOI: 10.1155/2022/5904332] [Reference Citation Analysis]
22 Blain H, Tuaillon E, Gamon L, Pisoni A, Miot S, Delpui V, Si-Mohamed N, Niel C, Rolland Y, Montes B, Groc S, Rafasse S, Dupuy AM, Gros N, Muriaux D, Picot MC, Bousquet J. Receptor binding domain-IgG levels correlate with protection in residents facing SARS-CoV-2 B.1.1.7 outbreaks. Allergy 2022;77:1885-94. [PMID: 34652831 DOI: 10.1111/all.15142] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
23 Cocoş R, Mahler B, Turcu-stiolica A, Stoichiță A, Ghinet A, Shelby E, Bohîlțea LC. Risk of Death in Comorbidity Subgroups of Hospitalized COVID-19 Patients Inferred by Routine Laboratory Markers of Systemic Inflammation on Admission: A Retrospective Study. Viruses 2022;14:1201. [DOI: 10.3390/v14061201] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
24 Atici Y, Kaçaroğlu D, Yilmaz A, Bakir F, Beşirbellioğlu BA, Yucel D, Yildirimkaya M. COVID-19 ENFEKSİYONUNDA HEMATOLOJİK VE ENFLAMATUVAR PARAMETRELERİN İNCELENMESİ. Avrasya Sağlık Bilimleri Dergisi 2022. [DOI: 10.53493/avrasyasbd.1062092] [Reference Citation Analysis]
25 Muhammadullah S, Urooj A, Mengal MH, Khan SA, Khalaj F. Cross-Sectional Analysis of Impulse Indicator Saturation Method for Outlier Detection Estimated via Regularization Techniques with Application of COVID-19 Data. Comput Math Methods Med 2022;2022:2588534. [PMID: 35529268 DOI: 10.1155/2022/2588534] [Reference Citation Analysis]
26 Alshammary AF, Alsughayyir JM, Alharbi KK, Al-sulaiman AM, Alshammary HF, Alshammary HF. T-Cell Subsets and Interleukin-10 Levels Are Predictors of Severity and Mortality in COVID-19: A Systematic Review and Meta-Analysis. Front Med 2022;9:852749. [DOI: 10.3389/fmed.2022.852749] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
27 Limon-de la Rosa N, Cervantes-alvarez E, Méndez-guerrero O, Gutierrez-gallardo MA, Kershenobich D, Navarro-alvarez N. Time-Dependent Changes of Laboratory Parameters as Independent Predictors of All-Cause Mortality in COVID-19 Patients. Biology 2022;11:580. [DOI: 10.3390/biology11040580] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Famiglini L, Campagner A, Carobene A, Cabitza F. A robust and parsimonious machine learning method to predict ICU admission of COVID-19 patients. Med Biol Eng Comput 2022. [PMID: 35353302 DOI: 10.1007/s11517-022-02543-x] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Gonzalez BL, de Oliveira NC, Ritter MR, Tonin FS, Melo EB, Sanches ACC, Fernandez-Llimos F, Petruco MV, de Mello JCP, Chierrito D, de Medeiros Araújo DC. The naturally-derived alkaloids as a potential treatment for COVID-19: A scoping review. Phytother Res 2022. [PMID: 35355337 DOI: 10.1002/ptr.7442] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
30 Assal HH, Abdel-hamid HM, Magdy S, Salah M, Ali A, Elkaffas RH, Sabry IM. Predictors of severity and mortality in COVID-19 patients. Egypt J Bronchol 2022;16. [DOI: 10.1186/s43168-022-00122-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Papadopoulou G, Manoloudi E, Repousi N, Skoura L, Hurst T, Karamitros T. Molecular and Clinical Prognostic Biomarkers of COVID-19 Severity and Persistence. Pathogens 2022;11:311. [DOI: 10.3390/pathogens11030311] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
32 Feltes BC, Vieira IA, Parraga-alava J, Meza J, Portmann E, Terán L, Dorn M. Feature selection reveal peripheral blood parameter's changes between COVID-19 infections patients from Brazil and Ecuador. Infection, Genetics and Evolution 2022;98:105228. [DOI: 10.1016/j.meegid.2022.105228] [Reference Citation Analysis]
33 Alghamdi A, Al Talhi Y, Al Najjar A, Sobhi A, Al Juaid A, Ibrahim A, Alshengeti A, Al-hebshi A, Farahat F, Al Qurainees G, Al Saif M, Hamdan N, Al Jehani S, Al Mansouri W, Aldabbagh M. Epidemiology, clinical characteristics and risk factors of COVID-19 among children in Saudi Arabia: a multicenter chart review study. BMC Pediatr 2022;22. [DOI: 10.1186/s12887-021-02959-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Niu J, Sareli C, Mayer D, Visbal A, Sareli A. Lymphopenia as a Predictor for Adverse Clinical Outcomes in Hospitalized Patients with COVID-19: A Single Center Retrospective Study of 4485 Cases. J Clin Med 2022;11:700. [PMID: 35160150 DOI: 10.3390/jcm11030700] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
35 Sokologorskiy SV, Ovechkin AM, Khapov IV, Politov ME, Bulanova EL. Risk Factors of Severe Disease and Methods for Clinical Outcome Prediction in Patients with COVID-19 (Review). Obŝaâ reanimatologiâ 2022;18:31-38. [DOI: 10.15360/1813-9779-2022-1-31-38] [Reference Citation Analysis]
36 Krishnamurthy V, Suhail KM, Aslam SSM, Raj MP, Patil P, Phaniraj P. Study of early warning efficiency of different laboratory markers in predicting progression of disease in COVID-19. Ann Afr Med 2022;21:371-6. [PMID: 36412337 DOI: 10.4103/aam.aam_117_21] [Reference Citation Analysis]
37 Sosnowska B, Bielecka-dabrowa A, Banach M. Prognosis in COVID-19 Patients: Statistics, Risk Factors. Contemporary Cardiology 2022. [DOI: 10.1007/978-3-031-15478-2_5] [Reference Citation Analysis]
38 Philips CA, Rela M, Soin AS, Gupta S, Surendran S, Augustine P. Critical Update on the Diagnosis and Management of COVID-19 in Advanced Cirrhosis and Liver Transplant Recipients. J Clin Transl Hepatol 2021;9:947-59. [PMID: 34966658 DOI: 10.14218/JCTH.2021.00228] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Blanch-Ruiz MA, Ortega-Luna R, Gómez-García G, Martínez-Cuesta MÁ, Álvarez Á. Role of Neutrophil Extracellular Traps in COVID-19 Progression: An Insight for Effective Treatment. Biomedicines 2021;10:31. [PMID: 35052711 DOI: 10.3390/biomedicines10010031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
40 Kageyama Y, Nishizaki Y, Aida K, Yayama K, Ebisui T, Akiyama T, Nakamura T. Lactobacillus plantarum induces innate cytokine responses that potentially provide a protective benefit against COVID-19: A single-arm, double-blind, prospective trial combined with an in vitro cytokine response assay. Exp Ther Med 2022;23:20. [PMID: 34815772 DOI: 10.3892/etm.2021.10942] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
41 Al-Saadi EAKD, Abdulnabi MA. Hematological changes associated with COVID-19 infection. J Clin Lab Anal 2021;:e24064. [PMID: 34783405 DOI: 10.1002/jcla.24064] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
42 Clavijo MM, Vicente Reparaz MLA, Ruiz JI, Acuña MA, Casali CE, Aizpurua MF, Mahuad CV, Eciolaza S, Ventura A, Garate GM. Mild COVID-19 Illness as a Risk Factor for Venous Thromboembolism. Cureus 2021;13:e18236. [PMID: 34722035 DOI: 10.7759/cureus.18236] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 Shi Q, Wang Z, Liu J, Wang X, Zhou Q, Li Q, Yu Y, Luo Z, Liu E, Chen Y; COVID-19 evidence and recommendations working group. Risk factors for poor prognosis in children and adolescents with COVID-19: A systematic review and meta-analysis. EClinicalMedicine 2021;41:101155. [PMID: 34693233 DOI: 10.1016/j.eclinm.2021.101155] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
44 Peng TJ, Jasne AS, Simonov M, Abdelhakim S, Kone G, Cheng YK, Rethana M, Tarasaria K, Herman AL, Baker AD, Yaghi S, Frontera JA, Sansing LH, Falcone GJ, Spudich S, Schindler J, Sheth KN, Sharma R. Prior Stroke and Age Predict Acute Ischemic Stroke Among Hospitalized COVID-19 Patients: A Derivation and Validation Study. Front Neurol 2021;12:741044. [PMID: 34675873 DOI: 10.3389/fneur.2021.741044] [Reference Citation Analysis]
45 Baltoumas FA, Zafeiropoulou S, Karatzas E, Paragkamian S, Thanati F, Iliopoulos I, Eliopoulos AG, Schneider R, Jensen LJ, Pafilis E, Pavlopoulos GA. OnTheFly2.0: a text-mining web application for automated biomedical entity recognition, document annotation, network and functional enrichment analysis. NAR Genom Bioinform 2021;3:lqab090. [PMID: 34632381 DOI: 10.1093/nargab/lqab090] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
46 Cafardi J, Haas D, Lamarre T, Feinberg J. Opportunistic Fungal Infection Associated With COVID-19. Open Forum Infect Dis 2021;8:ofab016. [PMID: 34621913 DOI: 10.1093/ofid/ofab016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
47 Beydoğan E, Yürük Atasoy P. The relationship between CRP at admission and thorax CT findings in patients diagnosed with COVID-19. Int J Clin Pract 2021;:e14962. [PMID: 34624163 DOI: 10.1111/ijcp.14962] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
48 Myari A, Papapetrou E, Tsaousi C. Diagnostic value of white blood cell parameters for COVID-19: Is there a role for HFLC and IG? Int J Lab Hematol 2021. [PMID: 34623763 DOI: 10.1111/ijlh.13728] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
49 Khalid M, Awan S, Jatoi NN, Jatoi HN, Yasmin F, Ochani RK, Batra S, Malik F, Ahmed J, Chawla S, Mustafa A, Lak HM, Surani S. Cardiac manifestations of the coronavirus disease-19: a review of pathogenesis, clinical manifestations, diagnosis, and treatment. Pan Afr Med J 2021;39:173. [PMID: 34584599 DOI: 10.11604/pamj.2021.39.173.27802] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Cihakova D, Streiff MB, Menez SP, Chen TK, Gilotra NA, Michos ED, Marr KA, Karaba AH, Robinson ML, Blair PW, Dioverti MV, Post WS, Cox AL, R Antar AA. High-value laboratory testing for hospitalized COVID-19 patients: a review. Future Virol 2021. [PMID: 34567235 DOI: 10.2217/fvl-2020-0316] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
51 Wolfisberg S, Gregoriano C, Schuetz P. Procalcitonin for individualizing antibiotic treatment: an update with a focus on COVID-19. Crit Rev Clin Lab Sci 2021;:1-12. [PMID: 34517744 DOI: 10.1080/10408363.2021.1975637] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
52 Toraih EA, Elshazli RM, Trinh LN, Hussein MH, Attia AA, Ruiz EML, Zerfaoui M, Fawzy MS, Kandil E. Diagnostic and Prognostic Performance of Liquid Biopsy-Derived Exosomal MicroRNAs in Thyroid Cancer Patients: A Systematic Review and Meta-Analysis. Cancers (Basel) 2021;13:4295. [PMID: 34503104 DOI: 10.3390/cancers13174295] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
53 Llamas M, Garo ML, Giovanella L. Low free-T3 serum levels and prognosis of COVID-19: systematic review and meta-analysis. Clin Chem Lab Med 2021. [PMID: 34380183 DOI: 10.1515/cclm-2021-0805] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
54 Wilson S, Bohn MK, Hall A, Higgins V, Abdelhaleem M, Adeli K. Continuous reference curves for common hematology markers in the CALIPER cohort of healthy children and adolescents on the Sysmex XN-3000 system. Int J Lab Hematol 2021. [PMID: 34333858 DOI: 10.1111/ijlh.13670] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Badimon L, Robinson EL, Jusic A, Carpusca I, deWindt LJ, Emanueli C, Ferdinandy P, Gu W, Gyöngyösi M, Hackl M, Karaduzovic-Hadziabdic K, Lustrek M, Martelli F, Nham E, Potočnjak I, Satagopam V, Schneider R, Thum T, Devaux Y. Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST Action CA17129. Cardiovasc Res 2021;117:1823-40. [PMID: 33839767 DOI: 10.1093/cvr/cvab094] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
56 Tuncer G, Surme S, Bayramlar OF, Karanalbant HK, Copur B, Yazla M, Zerdali E, Nakir IY, Cinar AR, Buyukyazgan A, Balli H, Kurekci Y, Simsek-Yavuz S, Sonmez MM, Sengoz G, Pehlivanoglu F. National Early Warning Score 2 and laboratory predictors correlate with clinical deterioration in hospitalized patients with COVID-19. Biomark Med 2021;15:807-20. [PMID: 34284639 DOI: 10.2217/bmm-2021-0061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
57 Szklanna PB, Altaie H, Comer SP, Cullivan S, Kelliher S, Weiss L, Curran J, Dowling E, O'Reilly KMA, Cotter AG, Marsh B, Gaine S, Power N, Lennon Á, McCullagh B, Ní Áinle F, Kevane B, Maguire PB. Routine Hematological Parameters May Be Predictors of COVID-19 Severity. Front Med (Lausanne) 2021;8:682843. [PMID: 34336889 DOI: 10.3389/fmed.2021.682843] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
58 Alay H, Laloglu E. The role of angiopoietin-2 and surfactant protein-D levels in SARS-CoV-2-related lung injury: A prospective, observational, cohort study. J Med Virol 2021;93:6008-15. [PMID: 34232533 DOI: 10.1002/jmv.27184] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
59 Codd AS, Hanna SJ, Compeer EB, Richter FC, Pring EJ, Gea-mallorquí E, Borsa M, Moon OR, Scourfield DO, Ahern DJ, Almuttaqi H, Alonzi DS, Alrubayyi A, Alsaleh G, Bart VMT, Batchelor V, Bayliss R, Berthold DL, Bezbradica JS, Bharuchq T, Borrmann H, Borsa M, Borst R, Brun J, Burnell S, Capitani L, Cavounidis A, Chapman L, Chauveau A, Cifuentes L, Codd AS, Compeer EB, Coveney C, Cross A, Danielli S, Davies LC, Dendrou CA, Dimonte S, Durairaj RRP, Dustin LB, Dyer A, Fielding C, Fischer F, Gallimore A, Galloway S, Gammage A, Gea-mallorquí E, Godkin A, Hanna SJ, Heuberger C, Hulin-curtis S, Issa F, Jones E, Jones R, Ladell K, Lauder SN, Liddiard K, Ligoxygakis P, Lu F, Maclachlan B, Maleki-toyserkani S, Mann EH, Marzeda AM, Matthews RJ, Mazet JM, Milicic A, Mitchell E, Moon O, Nguyen VD, O'hanlon M, Pavillet CE, Peppa D, Pires A, Pring E, Quastel M, Reed S, Rehwinkel J, Richmond N, Richter FC, Robinson AJB, Rodrigues PRS, Sabberwal P, Sami A, Peres RS, Sattentau Q, Schonfeldova B, Scourfield DO, Selvakumar TA, Shepherd FR, Shorten C, Simon AK, Smith AL, Crespo AT, Tellier M, Thornton E, Uhl LFK, van Grinsven E, Wann AKT, Williams R, Wilson JD, Zhou D, Zhu Z, Gallimore AM, Milicic A; Oxford-Cardiff COVID-19 Literature Consortium. Neutrophilia, lymphopenia and myeloid dysfunction: a living review of the quantitative changes to innate and adaptive immune cells which define COVID-19 pathology. Oxford Open Immunology 2021;2:iqab016. [DOI: 10.1093/oxfimm/iqab016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
60 Monárrez-Espino J, Zubía-Nevárez CI, Reyes-Silva L, Castillo-Palencia JP, Castañeda-Delgado JE, Herrera van-Oostdam AS, López-Hernández Y. Clinical Factors Associated with COVID-19 Severity in Mexican Patients: Cross-Sectional Analysis from a Multicentric Hospital Study. Healthcare (Basel) 2021;9:895. [PMID: 34356272 DOI: 10.3390/healthcare9070895] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Gracia-Ramos AE, Jaquez-Quintana JO, Contreras-Omaña R, Auron M. Liver dysfunction and SARS-CoV-2 infection. World J Gastroenterol 2021; 27(26): 3951-3970 [PMID: 34326607 DOI: 10.3748/wjg.v27.i26.3951] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
62 Avci BŞ, Kaya A, Sümbül HE, İçme F, Yeşilağaç H, Ünal N, Yeşiloğlu Ö, Çinar H, Turunç T. Relationship between Covid-19-associated pneumonia severity with coagulopathy and mortality. Cukurova Medical Journal 2021;46:540-7. [DOI: 10.17826/cumj.864023] [Reference Citation Analysis]
63 Ticinesi A, Nouvenne A, Prati B, Guida L, Parise A, Cerundolo N, Bonaguri C, Aloe R, Guerra A, Meschi T. The Clinical Significance of Procalcitonin Elevation in Patients over 75 Years Old Admitted for COVID-19 Pneumonia. Mediators Inflamm 2021;2021:5593806. [PMID: 34326704 DOI: 10.1155/2021/5593806] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
64 AbdAllah NB, Toraih EA, Al Ageeli E, Elhagrasy H, Gouda NS, Fawzy MS, Helal GM. MYD88, NFKB1, and IL6 transcripts overexpression are associated with poor outcomes and short survival in neonatal sepsis. Sci Rep 2021;11:13374. [PMID: 34183713 DOI: 10.1038/s41598-021-92912-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
65 Kilbaş İ, Kahraman EP, Ciftci İ. Prokalsitonin Seviyesinin Covid-19 Enfeksiyonun Şiddetiyle İlişkisi. Phoenix Medical Journal 2021. [DOI: 10.38175/phnx.899465] [Reference Citation Analysis]
66 Thomsen K, Pedersen HP, Iversen S, Wiese L, Fuursted K, Nielsen HV, Christensen JJE, Nielsen XC. Extensive microbiological respiratory tract specimen characterization in critically ill COVID-19 patients. APMIS 2021;129:431-7. [PMID: 33950572 DOI: 10.1111/apm.13143] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
67 Hazeldine J, Lord JM. Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets. Front Immunol 2021;12:680134. [PMID: 34149717 DOI: 10.3389/fimmu.2021.680134] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 11.5] [Reference Citation Analysis]
68 [DOI: 10.1109/cbms52027.2021.00065] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
69 Bhoopat L, Martynova A, Choi A, Pattaranithima P, Han S, Du S, Syed I, Chan C, Oh EE, Borok Z, Liebler J, Lee Wilson M, Tantiyavarong P, O'connell C. WITHDRAWN: A dynamic, D-dimer-based thromboprophylaxis strategy in patients with COVID-19. Thrombosis Update 2021. [DOI: 10.1016/j.tru.2021.100055] [Reference Citation Analysis]
70 Kumar A, Sepolia S, Shilpa RH, Rezayani G, Kumari S, Aastha, Gupta S. Role of Hematological and Immunological Parameters in COVID-19 Patients. J Pharm Bioallied Sci 2021;13:238-43. [PMID: 34349485 DOI: 10.4103/jpbs.JPBS_655_20] [Reference Citation Analysis]
71 Tantry US, Bliden KP, Cho A, Walia N, Dahlen JR, Ens G, Traianova M, Jerjian C, Usman A, Gurbel PA. First Experience Addressing the Prognostic Utility of Novel Urinary Biomarkers in Patients With COVID-19. Open Forum Infect Dis 2021;8:ofab274. [PMID: 34250193 DOI: 10.1093/ofid/ofab274] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
72 Waris A, Din M, Khalid A, Abbas Lail R, Shaheen A, Khan N, Nawaz M, Baset A, Ahmad I, Ali M. Evaluation of hematological parameters as an indicator of disease severity in Covid-19 patients: Pakistan's experience. J Clin Lab Anal 2021;35:e23809. [PMID: 34028884 DOI: 10.1002/jcla.23809] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
73 Hashem MK, Khedr EM, Daef E, Mohamed-hussein A, Mostafa EF, Hassany SM, Galal H, Hassan SA, Galal I, Amin MT, Hassan HM. Prognostic biomarkers in COVID-19 infection: value of anemia, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and D-dimer. Egypt J Bronchol 2021;15. [DOI: 10.1186/s43168-021-00075-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
74 Martín MC, Jurado A, Abad-Molina C, Orduña A, Yarce O, Navas AM, Cunill V, Escobar D, Boix F, Burillo-Sanz S, Vegas-Sánchez MC, Jiménez-de Las Pozas Y, Melero J, Aguilar M, Sobieschi OI, López-Hoyos M, Ocejo-Vinyals G, San Segundo D, Almeida D, Medina S, Fernández L, Vergara E, Quirant B, Martínez-Cáceres E, Boiges M, Alonso M, Esparcia-Pinedo L, López-Sanz C, Muñoz-Vico J, López-Palmero S, Trujillo A, Álvarez P, Prada Á, Monzón D, Ontañón J, Marco FM, Mora S, Rojo R, González-Martínez G, Martínez-Saavedra MT, Gil-Herrera J, Cantenys-Molina S, Hernández M, Perurena-Prieto J, Rodríguez-Bayona B, Martínez A, Ocaña E, Molina J. The age again in the eye of the COVID-19 storm: evidence-based decision making. Immun Ageing 2021;18:24. [PMID: 34016150 DOI: 10.1186/s12979-021-00237-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
75 Stringer D, Braude P, Myint PK, Evans L, Collins JT, Verduri A, Quinn TJ, Vilches-Moraga A, Stechman MJ, Pearce L, Moug S, McCarthy K, Hewitt J, Carter B; COPE Study Collaborators. The role of C-reactive protein as a prognostic marker in COVID-19. Int J Epidemiol 2021;50:420-9. [PMID: 33683344 DOI: 10.1093/ije/dyab012] [Cited by in Crossref: 49] [Cited by in F6Publishing: 55] [Article Influence: 24.5] [Reference Citation Analysis]
76 Baltoumas FA, Zafeiropoulou S, Karatzas E, Paragkamian S, Thanati F, Iliopoulos I, Eliopoulos AG, Schneider R, Jensen LJ, Pafilis E, Pavlopoulos GA. OnTheFly2.0: a text-mining web application for automated biomedical entity recognition, document annotation, network and functional enrichment analysis.. [DOI: 10.1101/2021.05.14.444150] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
77 Böncüoğlu E, Coşkun M, Kıymet E, Öztürk Atasoy T, Şahinkaya Ş, Cem E, Düzgöl M, Yılmaz Çelebi M, Akaslan Kara A, Arıkan KÖ, Bayram N, Devrim İ. Can laboratory findings predict pulmonary involvement in children with COVID-19 infection? Pediatr Pulmonol 2021;56:2489-94. [PMID: 33983678 DOI: 10.1002/ppul.25452] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
78 da Silva RP, Gonçalves JIB, Zanin RF, Schuch FB, de Souza APD. Circulating Type I Interferon Levels and COVID-19 Severity: A Systematic Review and Meta-Analysis. Front Immunol 2021;12:657363. [PMID: 34054820 DOI: 10.3389/fimmu.2021.657363] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
79 Song J, Park DW, Cha JH, Seok H, Kim JY, Park J, Cho H. Clinical course and risk factors of fatal adverse outcomes in COVID-19 patients in Korea: a nationwide retrospective cohort study. Sci Rep 2021;11:10066. [PMID: 33980912 DOI: 10.1038/s41598-021-89548-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
80 Chakraborty T, Jamal RF, Battineni G, Teja KV, Marto CM, Spagnuolo G. A Review of Prolonged Post-COVID-19 Symptoms and Their Implications on Dental Management. Int J Environ Res Public Health 2021;18:5131. [PMID: 34066174 DOI: 10.3390/ijerph18105131] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
81 Dewi R, Kaswandani N, Karyanti MR, Setyanto DB, Pudjiadi AH, Hendarto A, Djer MM, Prayitno A, Yuniar I, Indawati W, Prawira Y, Handryastuti S, Sjakti HA, Hidayati EL, Muktiarti D, Soebadi A, Puspaningtyas NW, Muhaimin R, Rahmadhany A, Octavius GS, Puspitasari HA, Jasin MR, Tartila T, Putri ND. Mortality in children with positive SARS-CoV-2 polymerase chain reaction test: Lessons learned from a tertiary referral hospital in Indonesia. Int J Infect Dis 2021;107:78-85. [PMID: 33857609 DOI: 10.1016/j.ijid.2021.04.019] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
82 Ismail F, Farag A, Haq S, Kamal MA. Clinical Characteristics of the First 100 Patients of COVID-19 in Tobruk, Libya: A Brief Report From Low-Resource Settings. Disaster Med Public Health Prep 2021;:1-4. [PMID: 33867007 DOI: 10.1017/dmp.2021.123] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
83 Hariyanto TI, Valeriani K, Kwenandar F, Damay V, Siregar JI, Lugito NPH, Tjiang MM, Kurniawan A. Deriving cut-off values through meta-analysis of individual studies. Am J Emerg Med 2021:S0735-6757(21)00263-1. [PMID: 33863560 DOI: 10.1016/j.ajem.2021.03.077] [Reference Citation Analysis]
84 Schwarz T, Heiss K, Mahendran Y, Casilag F, Kurth F, Sander LE, Wendtner CM, Hoechstetter MA, Müller MA, Sekul R, Drosten C, Stadler V, Corman VM. SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients. Front Immunol 2021;12:629185. [PMID: 33833755 DOI: 10.3389/fimmu.2021.629185] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
85 Moosavi M, Wooten M, Goodman A, Nahab FB, Duncan A, Maier C, Guarner J. Retrospective Analyses Associate Hemostasis Activation Biomarkers With Poor Outcomes in Patients With COVID-19. Am J Clin Pathol 2021;155:498-505. [PMID: 33300981 DOI: 10.1093/ajcp/aqaa266] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
86 Shanbehzadeh M, Kazemi-Arpanahi H, Nopour R. Performance evaluation of selected decision tree algorithms for COVID-19 diagnosis using routine clinical data. Med J Islam Repub Iran 2021;35:29. [PMID: 34169041 DOI: 10.47176/mjiri.35.29] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
87 Pinilla L, Benitez ID, González J, Torres G, Barbé F, de Gonzalo-Calvo D. Peripheral blood microRNAs and the COVID-19 patient: methodological considerations, technical challenges and practice points. RNA Biol 2021;18:688-95. [PMID: 33530819 DOI: 10.1080/15476286.2021.1885188] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
88 Heffernan AJ, Denny KJ. Host Diagnostic Biomarkers of Infection in the ICU: Where Are We and Where Are We Going? Curr Infect Dis Rep 2021;23:4. [PMID: 33613126 DOI: 10.1007/s11908-021-00747-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
89 Kantri A, Ziati J, Khalis M, Haoudar A, El Aidaoui K, Daoudi Y, Chikhaoui I, El Yamani K, Mouhaoui M, El Bakkouri J, Dini N, Mahi M, Naitlho A, Bahlaoui A, Bennana A, Noussair M, Belyamani L, El Kettani C. Hematological and biochemical abnormalities associated with severe forms of COVID-19: A retrospective single-center study from Morocco. PLoS One 2021;16:e0246295. [PMID: 33539383 DOI: 10.1371/journal.pone.0246295] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
90 Iglesias-osores S, Rafael-heredia A, Rojas-tello ER, Ortiz-uribe WA, Román LW, Armando LO, Miguel A, Córdova-rojas LM, López-lópez E, Failoc-rojas VE. Prognosis and hematological findings in patients with COVID-19 in an Amazonian population of Peru.. [DOI: 10.1101/2021.01.31.21250859] [Reference Citation Analysis]
91 Dhar SK, K V, Damodar S, Gujar S, Das M. IL-6 and IL-10 as predictors of disease severity in COVID-19 patients: results from meta-analysis and regression. Heliyon 2021;7:e06155. [PMID: 33553782 DOI: 10.1016/j.heliyon.2021.e06155] [Cited by in Crossref: 64] [Cited by in F6Publishing: 74] [Article Influence: 32.0] [Reference Citation Analysis]
92 Schultz MJ, Gebremariam TH, Park C, Pisani L, Sivakorn C, Taran S, Papali A; COVID–LMIC Task Force and the Mahidol–Oxford Research Unit (MORU), Bangkok, Thailand. Pragmatic Recommendations for the Use of Diagnostic Testing and Prognostic Models in Hospitalized Patients with Severe COVID-19 in Low- and Middle-Income Countries. Am J Trop Med Hyg 2021:tpmd200730. [PMID: 33534752 DOI: 10.4269/ajtmh.20-0730] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
93 Tuncer G, Surme S, Bayramlar OF, Karanalbant HK, Copur B, Yazla M, Zerdali E, Nakir IY, Cinar AK, Buyukyazgan A, Balli H, Kurekci Y, Yavuz SS, Sonmez MM, Sengoz G, Pehlivanoglu F. NEWS2 and laboratory predictors correlated with clinical deterioration in hospitalised patients with COVID-19.. [DOI: 10.1101/2021.01.17.21249878] [Reference Citation Analysis]
94 Abers MS, Delmonte OM, Ricotta EE, Fintzi J, Fink DL, de Jesus AAA, Zarember KA, Alehashemi S, Oikonomou V, Desai JV, Canna SW, Shakoory B, Dobbs K, Imberti L, Sottini A, Quiros-Roldan E, Castelli F, Rossi C, Brugnoni D, Biondi A, Bettini LR, D'Angio' M, Bonfanti P, Castagnoli R, Montagna D, Licari A, Marseglia GL, Gliniewicz EF, Shaw E, Kahle DE, Rastegar AT, Stack M, Myint-Hpu K, Levinson SL, DiNubile MJ, Chertow DW, Burbelo PD, Cohen JI, Calvo KR, Tsang JS, Su HC, Gallin JI, Kuhns DB, Goldbach-Mansky R, Lionakis MS, Notarangelo LD; NIAID COVID-19 Consortium. An immune-based biomarker signature is associated with mortality in COVID-19 patients. JCI Insight 2021;6:144455. [PMID: 33232303 DOI: 10.1172/jci.insight.144455] [Cited by in Crossref: 157] [Cited by in F6Publishing: 174] [Article Influence: 78.5] [Reference Citation Analysis]
95 Filgueira LM, Cervantes JB, Lovelle OA, Herrera C, Figueredo C, Caballero JA, Sánchez N, Berrio J, Lorenzo G, Cepeda M, Ramos M, Saavedra D, Añe-Kouri AL, Mazorra Z, Leon K, Crombet T, Caballero A. An anti-CD6 antibody for the treatment of COVID-19 patients with cytokine-release syndrome: report of three cases. Immunotherapy 2021;13:289-95. [PMID: 33397150 DOI: 10.2217/imt-2020-0235] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
96 Rubio-sánchez R, Esteban de Celis MDC, Zárate M, Giménez Blanco M, Viloria-peñas MDM. Risk factors for death in patients with SARS-CoV-2 infection admitted to the ICU. Rev Med Lab 2021. [DOI: 10.20960/revmedlab.00090] [Reference Citation Analysis]
97 Viksna L, Kolesova O, Kolesovs A, Vanaga I, Arutjunana S, Laivacuma S, Storozenko J, Tolmane I, Berzina I, Rozentale B. Clinical characteristics of COVID-19 patients in Latvia under low incidence in Spring 2020.. [DOI: 10.1101/2020.12.22.20239392] [Reference Citation Analysis]
98 Arutyunov GP, Tarlovskaya EI, Arutyunov AG, Belenkov YN, Konradi AO, Lopatin YM, Tereshchenko SN, Rebrov AP, Chesnikova AI, Fomin IV, Grigorieva NV, Boldina MV, Vaisberg AR, Blagonravova AS, Makarova EV, Shaposhnik II, Kuznetsova TY, Malchikova SV, Protsenko DN, Evzerikhina AV, Petrova MM, Demko IV, Saphonov DV, Hayrapetyan HG, Galyavich AS, Kim ZF, Sugraliev AB, Nedogoda SV, Tsoma VV, Sayganov SA, Gomonova VV, Gubareva IV, Sarybaev AS, Koroleva EV, Vilkova OE, Fomina IY, Pudova IA, Soloveva DV, Kiseleva NV, Zelyaeva NV, Kouranova IM, Pogrebetskaya VA, Muradova FN, Badina OY, Kovalishena OV, Galova EA, Plastinina SS, Lyubavina NA, Vezikova NN, Levankova VI, Ivanova SY, Ermilova AN, Muradyan RG, Gostishev RV, Tikhonova EP, Kuzmina TY, Soloveva IA, Kraposhina AY, Kolyadich MI, Kolchinskaya TP, Genkel VV, Kuznetsova AS, Kazakovtseva MV, Odegova AA, Chudinovskikh TI, Baramzina SV, Rozanova NA, Kerimova AS, Krivosheina NA, Chukhlova SY, Levchenko AA, Avoyan HG, Azarian KK, Musaelian SN, Avetisian SA, Levin ME, Karpov OV, Sokhova FM, Burygina LA, Sheshina TV, Tiurin AA, Dolgikh OY, Kazymova EV, Konstantinov DY, Chumakova OA, Kondriakova OV, Shishkov KY, Fil TS, Prokofeva NA, Konoval MP, Simonov AA, Bitieva AM, Trostianetckaia NA, Cholponbaeva MB, Kerimbekova ZB, Duyshobayev MY, Akunov AC, Kushubakova NA, Melnikov ES, Kim ES, Sherbakov SY, Trofimov DA, Evdokimov DS, Ayipova DA, Duvanov IA, Abdrahmanova AK, Aimakhanova GT, Ospanova SO, Dabylova GM, Tursunova AT, Xaskaeva DS, Tulichev AA, Ashina EY, Kordukova VA, Barisheva OY, Egorova KE, Varlamova DD, Kuprina TV, Pahomova EV, Kurchugina NY, Frolova IA, Mazalov KV, Subbotin AK, Kamardina NA, Zarechnova NV, Mamutova EM, Smirnova LA, Klimova AV, Shakhgildyan LD, Tokmin DS, Tupitsin DI, Kriukova TV, Rakov NA, Polyakov DS. International register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors” (AKTIV SARS-CoV-2): analysis of 1,000 patients. Russ J Cardiol 2020;25:4165. [DOI: 10.15829/29/1560-4071-2020-4165] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
99 Tomo S, Karli S, Dharmalingam K, Yadav D, Sharma P. The Clinical Laboratory: A Key Player in Diagnosis and Management of COVID-19. EJIFCC 2020;31:326-46. [PMID: 33376473] [Reference Citation Analysis]
100 Hariyanto TI, Putri C, Arisa J, Situmeang RFV, Kurniawan A. Dementia and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A systematic review and meta-analysis. Arch Gerontol Geriatr 2021;93:104299. [PMID: 33285424 DOI: 10.1016/j.archger.2020.104299] [Cited by in Crossref: 52] [Cited by in F6Publishing: 39] [Article Influence: 17.3] [Reference Citation Analysis]
101 K.rostam SR, Shekhany KAM, Smail HO. COMPARATIVE STUDY of SOME BIOCHEMICAL PARAMETERS AMONG of COVID-19 SYMPTOMS and NON COVID-19 SYMPTOMS IN-DIVIDUALS. BIOV 2020;6. [DOI: 10.24233/biov.6.2.2020.180] [Reference Citation Analysis]
102 McCarthy K, Hewitt J, Myint PK, Quinn T, Carter B. Frailty and mortality in patients with COVID-19 - Authors' reply. Lancet Public Health 2020;5:e582. [PMID: 33120043 DOI: 10.1016/S2468-2667(20)30224-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
103 Yanai H. Metabolic Syndrome and COVID-19. Cardiol Res. 2020;11:360-365. [PMID: 33224380 DOI: 10.14740/cr1181] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 10.3] [Reference Citation Analysis]
104 Flick H. Letalität und Risikofaktoren für einen schweren Verlauf der COVID-19-Pneumonie. Pneumologe 2020;17:385-393. [DOI: 10.1007/s10405-020-00349-y] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
105 Díaz Y, Ramos-Suzarte M, Martín Y, Calderón NA, Santiago W, Viñet O, La O Y, Oyarzábal JPA, Pérez Y, Lorenzo G, Cepeda M, Saavedra D, Mazorra Z, Estevez D, Lorenzo-Luaces P, Valenzuela C, Caballero A, Leon K, Crombet T, Hidalgo CJ. Use of a Humanized Anti-CD6 Monoclonal Antibody (Itolizumab) in Elderly Patients with Moderate COVID-19. Gerontology 2020;66:553-61. [PMID: 33105142 DOI: 10.1159/000512210] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
106 Smith M, Lara OD, O'Cearbhaill R, Knisely A, McEachron J, Gabor L, Carr C, Blank S, Prasad-Hayes M, Frey M, Jee J, Fehniger J, Wang Y, Lee YC, Isani S, Wright JD, Pothuri B. Inflammatory markers in gynecologic oncology patients hospitalized with COVID-19 infection. Gynecol Oncol 2020;159:618-22. [PMID: 33019984 DOI: 10.1016/j.ygyno.2020.09.036] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
107 Jacobs JL, Mellors JW. Detection of SARS-CoV-2 RNA in Blood of Patients with COVID-19: What Does It Mean? Clin Infect Dis 2020:ciaa1316. [PMID: 32898242 DOI: 10.1093/cid/ciaa1316] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
108 Dhar SK, Vishnupriyan K, Damodar S, Gujar S, Das M. IL-6 and IL-10 as predictors of disease severity in COVID-19 patients: results from meta-analysis and regression.. [DOI: 10.1101/2020.08.15.20175844] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
109 Tomera K, kittah J. Famotidine with Celecoxib Adjuvant Therapy on Hospitalized COVID-19 Patients: A Case Series. SSRN Journal. [DOI: 10.2139/ssrn.3646583] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Reference Citation Analysis]